Viking Therapeutics (1VT.XETRA) Q3 2026 Earnings

29JulConfirmed
Q2 2026
Next
-1.17
-1.06
-0.95
-0.84

Details

Expected EPS
-1.0799136550000001
Actual EPS
N/A
Surprise EPS
1.08
Surprise Percent
+100%

Description

Viking Therapeutics (1VT.XETRA) will report earnings of for Q3 2026 on July 29, 2026.

0 Comments

Share your thoughts